That supports early-stage healthcare technologies with funding, guidance, and operational expertise to advance development.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Xontogeny is a life sciences accelerator that partners with entrepreneurs to develop early-stage healthcare technologies into viable companies. It provides strategic guidance, operational support, and seed investment to advance therapeutics, diagnostics, and medical innovations toward clinical validation. The company focuses on improving the success of early development through a collaborative, expertise-driven model.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Xontogeny Management Team
Investors
Perceptive Advisors
Xontogeny Valuations & Financials
View real-time NPM data on Xontogeny stock including daily Xontogeny stock price estimates, valuation history, and historical share price information. Access Xontogeny financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Xontogeny pricing across six independent market signals. Looking for private company due diligence data sources on Xontogeny? Get in touch to learn more.
Similar Companies
like Xontogeny
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
BrainHQ
Healthcare & Life Sciences
Empowers individuals to enhance memory, attention and thinking skills through adaptive cognitive exercises.
Tranquis Therapeutics
Develops small molecule drugs to restore immune cell function for treating neurodegenerative and aging-related diseases.
Sight Machine
Industrials
Enables streaming plant data into actionable insights for production improvement, root-cause detection and operational agility.
eQcell
Produces specialized stem cell therapies and regenerative treatments that target debilitating orthopedic conditions in animals.
Healthee
Healthcare & Life Sciences
Health tech company using AI to help employees make better healthcare decisions, improving outcomes and reducing costs.
Loanboox
A financial technology company that facilitates digital debt financing and management solutions for large borrowers and investors.
Neurala
AI & Machine Learning
Enables machines to analyze images and interpret visual data for automation tasks.
Intellimize
Automatically personalizes websites in real time using AI to boost revenue and customer acquisition for each unique visitor.
FAQ
We have answers
Xontogeny stock does not trade on public stock exchanges. Xontogeny stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Xontogeny stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Xontogeny Stock does not trade on public stock exchanges. In order to sell Xontogeny shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Xontogeny does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Xontogeny share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Xontogeny stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Xontogeny stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Xontogeny stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Xontogeny is a private company and has not had an IPO. There is currently no Xontogeny IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Xontogeny IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
